HomeIndustriesHomebuilding & Real EstateSAVA Stock Falls To New 52-Week Low

SAVA Stock Falls To New 52-Week Low

Cassava Sciences (SAVA) falls to a new 52-week low. A CUNY report shows “egregious misconduct” in SAVA’s research. The report highlights that they found questionable data management and record keeping. Twenty of the research papers in question provided “key support” for Simufilam, the company’s Alzheimer’s drug. Jenny Horne weighs in on this story. Tune in to find out more about the stock market today.

Market On Close

13 Oct 2023

SHARE

ON AIR
3:00 pm
Market Overtime
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
education
5:00 am
Liz Ann Live
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Market Overtime
REPLAY
8:00 am
Market Overtime
REPLAY
8:30 am
Market On Close
REPLAY
education
10:00 am
Schwab 2026 Outlook
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Liz Ann Live
REPLAY
1:30 pm
The Wrap
REPLAY
ON AIR
3:00 pm
Market Overtime
REPLAY
4:00 pm
Market Overtime
REPLAY
4:30 pm
Market On Close
REPLAY
education
6:00 pm
Schwab 2026 Outlook
REPLAY
7:00 pm
Fast Market
REPLAY
8:00 pm
Next Gen Investing
REPLAY
education
9:00 pm
Liz Ann Live
REPLAY
9:30 pm
The Wrap
REPLAY
11:00 pm
Market Overtime
REPLAY

Schwab Network's Newsletters

Daily insights for every investor